The results demonstrated that 16 of 27 (59.3%) tumor species exhibited high G6PD expression levels (Fig. 5a), and the statistical analysis revealed that the mRNA expression level of G6PD was significantly increased in ccRCC species compared with normal tissues (Fig. 5b). This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.